Scientific Article
previous document  unige:113715  next document
add to browser collection
Title

Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease mice

Authors
Almeida, Camila Bononi
Jang, Jung-Eun
Prophete, Colette
Costa, Fernando Ferreira
Conran, Nicola
Frenette, Paul S
Published in Blood. 2012, vol. 120, no. 14, p. 2879-2888
Abstract Inhibition of leukocyte adhesion to the vascular endothelium represents a novel and important approach for decreasing sickle cell disease (SCD) vaso-occlusion. Using a humanized SCD-mouse-model of tumor necrosis factor-α-induced acute vaso-occlusion, we herein present data demonstrating that short-term administration of either hydroxyurea or the phosphodiesterase 9 (PDE9) inhibitor, BAY73-6691, significantly altered leukocyte recruitment to the microvasculature. Notably, the administration of both agents led to marked improvements in leukocyte rolling and adhesion and decreased heterotypic red blood cell-leukocyte interactions, coupled with prolonged animal survival. Mechanistically, these rheologic benefits were associated with decreased endothelial adhesion molecule expression, as well as diminished leukocyte Mac-1-integrin activation and cyclic guanosine monophosphate (cGMP)-signaling, leading to reduced leukocyte recruitment. Our findings indicate that hydroxyurea has immediate beneficial effects on the microvasculature in acute sickle-cell crises that are independent of the drug's fetal hemoglobin-elevating properties and probably involve the formation of intravascular nitric oxide. In addition, inhibition of PDE9, an enzyme highly expressed in hematopoietic cells, amplified the cGMP-elevating effects of hydroxyurea and may represent a promising and more tissue-specific adjuvant therapy for this disease.
Keywords 3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors/metabolismAcute DiseaseAnemia, Sickle Cell/chemically induced/drug therapy/metabolismAnimalsAntisickling Agents/therapeutic useCell Adhesion/drug effectsCell CommunicationCyclic GMP/metabolismDisease Models, AnimalEndothelium, Vascular/cytology/drug effects/metabolismErythrocytes/cytology/drug effectsFemaleHumansHydroxyurea/therapeutic useLeukocyte RollingLeukocytes/cytology/drug effectsMaleMiceMice, Inbred C57BLPyrazoles/pharmacologyPyrimidines/pharmacologyTumor Necrosis Factor-alpha/toxicityVascular Diseases/chemically induced/drug therapy/metabolism
Identifiers
PMID: 22833547
Full text
Article (Published version) (604 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research group L'influence du rôle du cycle circadien sur l'immunité (995)
Citation
(ISO format)
ALMEIDA, Camila Bononi et al. Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease mice. In: Blood, 2012, vol. 120, n° 14, p. 2879-2888. https://archive-ouverte.unige.ch/unige:113715

71 hits

1 download

Update

Deposited on : 2019-01-31

Export document
Format :
Citation style :